Cargando…
A Randomized Open-Label Study of Two Methods of Proton Pump Inhibitors Discontinuation
Background Proton pump inhibitors (PPIs) are effective in treating gastroesophageal reflux disease (GERD). Unfortunately, they are often inappropriately prescribed and long-term use has potential adverse effects. A single best method for discontinuation of PPIs does not currently exist. The objectiv...
Autores principales: | Hendricks, Emily, Ajmeri, Aman N, Singh, Monider M, Mongalo, Milliejoan, Goebel, Lynne J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8202782/ https://www.ncbi.nlm.nih.gov/pubmed/34150379 http://dx.doi.org/10.7759/cureus.15022 |
Ejemplares similares
-
Tumefactive Multiple Sclerosis, A Rare Variant Presenting as Multiple Ring-enhancing Lesions in an Immunocompetent Patient: A Case Report
por: Zaheer, Kamran, et al.
Publicado: (2018) -
Adverse Effects Associated with Proton Pump Inhibitor Use
por: Yibirin, Marcel, et al.
Publicado: (2021) -
Unusual Neurological Manifestation of Proton Pump Inhibitor: A Case Report of Acute Disseminated Encephalomyelitis and Severe Hyponatremia After Brief Use of Proton Pump Inhibitor
por: Qureshi, Ahmad S, et al.
Publicado: (2021) -
Argatroban Treatment and Decreased Fibrinogen in a Septic Patient
por: Ajmeri, Aman N, et al.
Publicado: (2020) -
Use of Proton Pump Inhibitors With Dexamethasone in Patients With COVID-19 Pneumonia: Contributions to Long-Term Polypharmacy
por: Singh, Ranbir, et al.
Publicado: (2022)